Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes
Authors:
- James BrugarolasJBJames Brugarolas
- William G KaelinWKWilliam G Kaelin
- 1 July 2004
- journal article
- review article
- Published by Elsevier in Cancer Cell
- Vol. 6 (1) , 7-10
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Signaling control of mRNA translation in cancer pathogenesisOncogene, 2004
- Survival signalling by Akt and eIF4E in oncogenesis and cancer therapyNature, 2004
- Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor GrowthPLOS Biology, 2003
- Will mTOR inhibitors make it as cancer drugs?Cancer Cell, 2003
- PTEN: One Gene, Many SyndromesHuman Mutation, 2003
- Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancerNature Genetics, 2002
- The Phosphoinositide 3-Kinase PathwayScience, 2002
- Loss of tuberin, the tuberous‐sclerosis‐complex‐2 gene product is associated with angiogenesisJournal of Cutaneous Pathology, 2001
- Hamartomatous Polyposis Syndromes: Molecular Genetics, Neoplastic Risk, and Surveillance RecommendationsAnnals of Surgical Oncology, 2001
- Peutz-Jeghers syndrome is caused by mutations in a novel serine threoninekinaseNature Genetics, 1998